OrbiMed Genesis GP LLC Insider Trades
EntityDirector at ADARx Pharmaceuticals, Inc. and 2 other companies. 3 significant open-market trades reported on SEC Form 4 in the last 180 days.
On EDGAR, this filer has 92 Form 4 filings on record since 2020, the latest on Nov 5, 2026. Full history on sec.gov
$71.1M
Bought
$0
Sold
3 / 0
Buys / Sells
3
Companies
Companies
Reported Trades
Open-market transactions only (code P and S), outside any 10b5-1 plan, dated by the day the filing reached EDGAR. Each row links to the filing.
Other Insiders at These Companies
Everyone else who reported a significant open-market trade at the same companies in the last 180 days. Several insiders buying at once is cluster buying.
- Erez ChimovitsDirector at ADRX1 buy, $1.0M
- Carl L. GordonDirector at ADRX1 buy, $16.1M
- Orbimed Advisors LLCDirector at ADRX1 buy, $16.1M
- OrbiMed Capital GP Vii LLCDirector at ADRX1 buy, $16.1M
- OrbiMed Israel GP Ii, L.P.Director at ADRX1 buy, $16.1M
- OrbiMed Advisors Israel II LtdDirector at ADRX1 buy, $16.1M
- SR One Capital Management, LLC10% owner at ADRX1 buy, $27.2M
- Simeon GeorgeDirector at ADRX1 buy, $27.2M
- Marc L. Andreessen10% owner at BRVE1 buy, $19.8M
- Benjamin A. Horowitz10% owner at BRVE1 buy, $19.8M
- Ah Bio Fund Iv, L.P.10% owner at BRVE1 buy, $19.8M
- Ah Equity Partners Bio Iv, L.L.C.10% owner at BRVE1 buy, $19.8M
How to Read This Page
These are the trades an insider chose to make with their own money, not grants, option exercises or tax withholding. A purchase is the stronger signal (why buys carry more information than sales), and an insider who buys is locked out of selling for six months by the short-swing rule. The window here is 180 days; the full filing history lives on EDGAR.
Get this insider's next buy when it files
InsiderWatch reads every Form 4 as it reaches EDGAR, keeps the open-market buys that matter, and sends them by email and Telegram.
Try free for 7 daysEvery alert we send is logged with its timestamp and source.